chrisvoncsefalvay/vaers-outcomes huggingface dataset:
expired moderna vaccine mistakenly administered; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (expired moderna vaccine mistakenly administered) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 ml. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (expired moderna vaccine mistakenly administered). At the time of the report, EXPIRED PRODUCT ADMINISTERED (expired moderna vaccine mistakenly administered) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication was mentioned. No treatment medication was mentioned.
Patient developed swelling of the neck and arm and required an emergency visit on 08/17/21
4 month old with intussusception-4 days after oral ROTATEQ (#2 dose).
Pain in arm of injection.  Flu-like symptoms - body aches, feeling cold, tired.
PATIENT PRESENTED WITH RASH ON R LEG.  RED, BUMPY, NO PAIN AFTER 1 DAY.
Complete loss of language, withdrawal into own world, fixation on spinning objects and simple tasks like turning light switch on and off. 60 day follow-up dated 6/28/00 provided a name spelling change.
I think the person had covid at the time; 6 months after the 2nd dose he then got a booster/3rd shot; 6 months after the 2nd dose he then got a booster/3rd shot; 102F fever; developed lumps on their neck; very tender and sore; left side back neck. Uncomfortable; hard time moving their head right and left; extremely tired; weak; developed lumps lymph node lumps same side as injection; tender and sore; This is a spontaneous report from a contactable consumer. A 42-year-old male patient received third dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection, Batch/Lot Number: was not reported), via an unspecified route of administration on an unspecified date (age at the time of vaccination 42-years-old), as a single dose for COVID-19 immunization. The patient medical history included toxoplasmosis, and mononucleosis. The patient concomitant medications were not reported. Patient previously received first dose of BNT162B2 vaccine, via an unspecified route of administration on an unspecified date (age at the time of vaccination 42-years-old), as a single dose for COVID-19 immunization; and second dose of BNT162B2 vaccine, via an unspecified route of administration on an unspecified date (age at the time of vaccination 42-years-old), as a single dose for COVID-19 immunization and experienced fever, achy, extremely tired. On an unspecified date, the patient experienced I think the person had covid at the time, 6 months after the 2nd dose he then got a booster/3rd shot, 102F fever, developed lumps on their neck; very tender and sore, left side back neck Uncomfortable, hard time moving their head right and left, extremely tired, weak, and developed lumps lymph node lumps same side as injection; tender and sore. On an unspecified date, the patient underwent lab tests and procedures which included Body temperature: 102 Fahrenheit, fever went down to 99.7 in about 3 days. Patient was put on an Amoxil treatment and then fever went down to 99.7 in 3 days. Patient saw a doctor who had no clue and put him on antibiotics. The outcome of the event 102F fever was recovering; and for all the events was unknown.  The lot number for the vaccine, (BNT162B2), was not provided and will be requested during follow-up
rash all over her body, itchiness and weakness for past 5 days; rash all over her body, itchiness and weakness for past 5 days; rash all over her body, itchiness and weakness for past 5 days; was rash and now it spread all over the body; started on 22Mar2021 as mild rash (delayed allergic reaction) on the arm and chest that was hot/swelling is down but rash is still persistent that looks like a allergic reaction; swelling under the armpits where lymph nodes are and stated that the underlying tissues was kind; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (rash all over her body, itchiness and weakness for past 5 days), ASTHENIA (rash all over her body, itchiness and weakness for past 5 days), RASH (rash all over her body, itchiness and weakness for past 5 days), RASH (was rash and now it spread all over the body) and HYPERSENSITIVITY (started on 22Mar2021 as mild rash (delayed allergic reaction) on the arm and chest that was hot/swelling is down but rash is still persistent that looks like a allergic reaction) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event.    On 11-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Mar-2021, the patient experienced RASH (was rash and now it spread all over the body), HYPERSENSITIVITY (started on 22Mar2021 as mild rash (delayed allergic reaction) on the arm and chest that was hot/swelling is down but rash is still persistent that looks like a allergic reaction) and LYMPHADENOPATHY (swelling under the armpits where lymph nodes are and stated that the underlying tissues was kind). On 28-Mar-2021, the patient experienced PRURITUS (rash all over her body, itchiness and weakness for past 5 days), ASTHENIA (rash all over her body, itchiness and weakness for past 5 days) and RASH (rash all over her body, itchiness and weakness for past 5 days). At the time of the report, PRURITUS (rash all over her body, itchiness and weakness for past 5 days), ASTHENIA (rash all over her body, itchiness and weakness for past 5 days), RASH (rash all over her body, itchiness and weakness for past 5 days), RASH (was rash and now it spread all over the body), HYPERSENSITIVITY (started on 22Mar2021 as mild rash (delayed allergic reaction) on the arm and chest that was hot/swelling is down but rash is still persistent that looks like a allergic reaction) and LYMPHADENOPATHY (swelling under the armpits where lymph nodes are and stated that the underlying tissues was kind) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       No treatment details were given.
Pt vaccinated with DTP/OPV continuous crying for over 4 hrs following injection, w/redness & swelling of thigh
Body pains; His lymph nodes were swollen; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (Body pains) and LYMPHADENOPATHY (His lymph nodes were swollen) in a 49-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Cancer (Cancer Survivor (2017)), Reactive arthritis and Immune system disorder (Weak Immune System). Concomitant products included TRAMADOL and PREGABALIN (LYRICA) for an unknown indication.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced MYALGIA (Body pains) and LYMPHADENOPATHY (His lymph nodes were swollen). At the time of the report, MYALGIA (Body pains) and LYMPHADENOPATHY (His lymph nodes were swollen) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment medications were provided.   This case was linked to MOD-2021-287356 (Patient Link).
After given 2nd dose of flu vaccine - patient sustained fever and vomiting.  Advised by doc more than likely exposed to illness in office, not vaccine reaction - but will file.
This spontaneous report was received from a Registered Nurse referring to a patient of unknown age and gender. Information regarding the patient's pertinent medical history, concurrent conditions, known allergies and concomitant medications was not reported. On 22-MAY-2017, the patient was vaccinated with a dose of VARIVAX (anatomical route of vaccination was not provided) for prophylaxis. On the same date, the patient was inadvertently administered with a dose of PROQUAD lot # M014301 (anatomical route of vaccination not provided) (accidental overdose). The vaccines were reconstituted with sterile diluent. It was reported that no adverse effects occurred and that no product quality issue was involved. Additional information has been requested.
Within 10 minutes started itching on arms, within 45 minutes hives started first on arms, then trunk, neck and ears.  During this time  throat began to get scratchy.  Took two 50mg of benadryl  then 1 hour later took one more 50mg of benadryl.  Within 3 hours hives and scratchy throat was gone.
gout in left ankle; This spontaneous case was reported by a consumer and describes the occurrence of GOUT (gout in left ankle) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. unknown) for COVID-19 vaccination.     No Medical History information was reported.    On 20-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Feb-2021, the patient experienced GOUT (gout in left ankle). At the time of the report, GOUT (gout in left ankle) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided No treatment information provided
She got a erythematous, macular rash over her thighs and trunk that spread over the next 24 hours to cover her face and eyelids. She had no fever and the rash was non-pruritic. It was more prominent in areas of friction under arms and inner thighs. Rash improved by 05/12. Treated with Benadryl.
This spontaneous report was received from a pharmacist refers to an 84 year old patient of unknown gender. No medical history or concurrent conditions were reported. On 14-DEC-2014, the patient was vaccinated with (Oka/Merck) VARIVAX, subcutaneous (dose, frequency, strength and lot number not provided). Co-suspect or concomitant therapies were not provided. The patient was inadvertently administered with (Oka/Merck) VARIVAX rather than ZOSTAVAX. No adverse effects reported. Additional information has been requested.
Patient received Moderna Covid-19 vaccine that underwent a temperature excursion; Patient received Moderna Covid-19 vaccine that underwent a temperature excursion; This spontaneous case was reported by a nurse and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (Patient received Moderna Covid-19 vaccine that underwent a temperature excursion) and POOR QUALITY PRODUCT ADMINISTERED (Patient received Moderna Covid-19 vaccine that underwent a temperature excursion) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 014B22A, 067F21A, 038B21A and 040A21A) for COVID-19 prophylaxis.     No Medical History information was reported.   On 18-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 14-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 15-Nov-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 01-Jul-2022, received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 01-Jul-2022,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Patient received Moderna Covid-19 vaccine that underwent a temperature excursion). On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Patient received Moderna Covid-19 vaccine that underwent a temperature excursion). At the time of the report, PRODUCT TEMPERATURE EXCURSION ISSUE (Patient received Moderna Covid-19 vaccine that underwent a temperature excursion) and POOR QUALITY PRODUCT ADMINISTERED (Patient received Moderna Covid-19 vaccine that underwent a temperature excursion) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications information was reported.  The Nurse had discovered 2 temperature excursions of the Moderna Covid-19 vaccine for two different lot numbers of the Moderna Covid-19 vaccine. The temperature in the refrigerator that the Moderna Covid-19 vaccine reached 13.1 degrees Celsius on 28-Jun-2022 and on 19-Jul-2022, the vaccine reached a temperature of 9 degrees Celsius. None of the vaccine in the refrigerator underwent two different temperature excursions.  The temperature excursion was not known of at the time of administration of the vaccine. The temperature excursion was found out about after a review of the temperature datalogger on the refrigerator that the Moderna Covid-19 vaccine was stored in. The Nurse had used the online Temperature excursion tool and was comfortable that her patient's dose was valid and that the affected vaccine was viable for future doses.  Side effects after any dose was reported as unknown.  No treatment medications were provided.
At 3:30 pm, pain in left side under ear/jaw area, pins and needles in jaw area starting. By 5:30 pm, pins and needles moving between jaw, top of head, left finger tips, and left cheek/sinus area. Took 1 Ibuprofen for neck/arm pain. Laid down at 5:30 pm. Fatigue. Cold enough to get a blanket but no chills. Laid down rest of the evening until bedtime. Woke up many times overnight from arm pain.
Patient describes as sore and swollen x2 days at injection site. Patient reports shoulder joint is not affected.
Chills; aches; low grade fever; shortness of breath; chest pain; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 46 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 21Oct2021 16:00 (Lot number: EC1384) at the age of 46 years as dose 2, single for covid-19 immunisation. Relevant medical history included: "Sleep apnea" (unspecified if ongoing); "Insomnia" (unspecified if ongoing); "seasonal allergies" (unspecified if ongoing); "Adenomas on adrenal gland and pituitary gland" (unspecified if ongoing), notes: Adenomas on adrenal gland and pituitary gland; "Known allergies: Crab" (unspecified if ongoing). Concomitant medication(s) included: FLU, administration date 30Sep2021. Past drug history included: Nsaids, reaction(s): "Allergies: NSAIDS". Vaccination history included: Bnt162b2 (Dose 1, single , Batch/Lot No: EW0186, Location of injection: Arm Left, Vaccine Administration Time: 10:00 AM), administration date: 30Sep2021, when the patient was 46 years old, for COVID-19 Immunization. The following information was reported: CHILLS (non-serious) with onset 21Oct2021, outcome "not recovered", described as "Chills"; PAIN (non-serious) with onset 21Oct2021, outcome "not recovered", described as "aches"; PYREXIA (non-serious) with onset 21Oct2021, outcome "not recovered", described as "low grade fever"; DYSPNOEA (non-serious) with onset 21Oct2021, outcome "not recovered", described as "shortness of breath"; CHEST PAIN (non-serious) with onset 21Oct2021, outcome "not recovered", described as "chest pain". Therapeutic measures were not taken as a result of chills, pain, pyrexia, dyspnoea, chest pain.  Additional Information: Prior to vaccination, the patient was not diagnosed with COVID-19. The patient received Flu shot within four weeks prior to COVID-19 vaccine and other prescribed medications in two weeks. Since the vaccination, the patient had not been tested for COVID-19.   No follow-up attempts are possible. No further information is expected.
It is possible that I got covid infection/had flu like symptoms; It is possible that I got covid infection/had flu like symptoms; This is a spontaneous report from a contactable consumer (patient). A male patient of an unspecified age received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiration date not reported), via an unspecified route of administration on 01Mar2021 as single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient was scheduled for the second dose today 23Mar2021. The patient had flu like symptoms with the first vaccination that seem eerily to close to COVID, and this was about 2 and a half weeks after the first dose. The patient stated that it was possible that he got COVID infection on 19Mar2021 and recovered. The patient went to get tested for the antibodies and it came back negative on an unspecified date. The testing place told him to get the rapid COVID test and if it came back negative, he should take the second dose of the vaccine. The patient was asking if he can take the second dose if he has or had COVID infection in between doses. The outcome of the events was recovered.  Information on the lot/batch number has been requested.
had the vaccine in February and the magnet sticking to vaccination site today 27May2021; This spontaneous case was reported by a patient and describes the occurrence of VACCINATION SITE REACTION (had the vaccine in February and the magnet sticking to vaccination site today 27May2021) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025J20-2A) for COVID-19 vaccination.     No Medical History information was reported.    On 06-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE REACTION (had the vaccine in February and the magnet sticking to vaccination site today 27May2021). At the time of the report, VACCINATION SITE REACTION (had the vaccine in February and the magnet sticking to vaccination site today 27May2021) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Headache, low back ache, site of injection soreness (3 days, including day of vaccine).
One day post vax, the pt experienced malaise, nausea, decreased appetite, stomach cramps, symptoms would resolve and then start again. Mom took child to ER. The pt was dx with increased liver enzymes, probably secondary to Hep B vaccine. Released to home.
I have my vaccination on 04/20/2022. On 08/25/2022 I had swollen glands and a sore throat. I took at home COVID-19 test and it was negative on the 08/25/2022. The following day 08/26/2022 I took another COVID-19 test and it was Positive. I contacted my physician who prescribed me Paxlovid.
Nausea, exhaustion, lightheaded/ dizziness, sore arm around injection site, light headache. lots of rest and hydration. symptoms lasted for 48 hours, only beginning the morning following the injection, (sore arm began right away).
Altered Mental Status     Pt arrived to ED via Ems with AMS. EMS reported Pt having occasional slurred speech.      HPI   100-year-old woman with history of A. fib, hypertension presents to the emergency department by EMS for altered mental status.  According to daughter that was initially at bedside the patient is normally oriented x3.  More recently she is only oriented to self.  Her speech has become nonsensical over the past week.  According to daughter she has been sleeping more than usual and having less oral intake.  Patient lives at a nursing facility.  Daughter states that patient had Covid 1 year ago.
herpes zoster; This initial spontaneous report was received from a lawyer regarding a case in litigation and refers to a currently 72 year old female patient. No information was provided regarding medical history, concurrent conditions, or concomitant medications.  On an unknown date in 2007, the patient was vaccinated with zoster vaccine live (ZOSTAVAX) (lot#, expiration date, dose, dose# and route not specified) for the long-term prevention of shingles and zoster-related conditions.   On an unspecified date, the patient experienced herpes zoster. On an unspecified date, the patient was treated by a physician for herpes zoster. The outcome of the events herpes zoster was not reported. The reporter considered the events to be related to zoster vaccine live (ZOSTAVAX).   Additional information has been requested.
warm; Swollen on the injection site (left arm); red (on the injection site); aching (on the injection site); This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (warm), VACCINATION SITE SWELLING (Swollen on the injection site (left arm)), VACCINATION SITE ERYTHEMA (red (on the injection site)) and VACCINATION SITE PAIN (aching (on the injection site)) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 0113J0A) for COVID-19 vaccination.     Concurrent medical conditions included AFib. Concomitant products included APIXABAN (ELIQUIS) for Atrial fibrillation.    On 07-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Jan-2021, the patient experienced VACCINATION SITE WARMTH (warm), VACCINATION SITE SWELLING (Swollen on the injection site (left arm)), VACCINATION SITE ERYTHEMA (red (on the injection site)) and VACCINATION SITE PAIN (aching (on the injection site)). The patient was treated with KETOROLAC TROMETHAMINE (TORADOL) for Pain, at a dose of 1 dosage form. At the time of the report, VACCINATION SITE WARMTH (warm), VACCINATION SITE SWELLING (Swollen on the injection site (left arm)), VACCINATION SITE ERYTHEMA (red (on the injection site)) and VACCINATION SITE PAIN (aching (on the injection site)) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Patient was schedule 2nd dose on February 4 Treatment medication information included Antibiotics   Most recent FOLLOW-UP information incorporated above includes: On 29-Jun-2021: TCR received contains No new Information; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
A few days after Vaccination I started feeling severe chills. I took night quill and went to sleep. I woke up and I had serve congestion and drainage and chills, Headaches. My eyes are watery and feel hot but I do not have a temp. I have body aches and joint, muscle and bone pain. 1/13 The symptoms have not gotten better. i called employee health and they stated to call VAERS. I am breast feeding and I'm not sure if this is happening because i am breast feeding. My milk supply has reduced by 50-75%. I tried to talk to a few MD's I know but I have not contact my PCP.
Immunizer gave immunization around 10 a.m.  Patient experienced nausea, vomiting, and diarrhea around 11:40 a.m.  No initial effects seen within 15 minute monitoring period of vaccine.  Patient stated they've never tested positive for Covid-19.  Nurse measured vitals.  Pulse 98   Temperature 97.2 F  BP  136/89  Patient needed to leave from work (was on duty).
Information has been received from a registered nurse concerning a patient of unknown age and gender. Patients' pertinent medical history, drug reactions or allergies were not reported. On 18-JAN-2016, the patient received an improperly stored dose of PROQUAD (Merck) with the lot # L032761, expiration date 24-FEB-2017 (dose, route and anatomical location of administration were not reported). The condition storage was 7F for 10 minutes. There was previous temperature excursion with 8F for 40 minutes and 18.2 F for 15 minutes. No concomitant therapy was provided. No adverse effects or reactions to this vaccine were reported. No product quality complaint (PQC) was involved. This is one of several reports from the same source. Additional information has been requested.